Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy (Q35963926)

11 August 2017

Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy (English)

1 reference

11 August 2017

1 reference

head and neck carcinoma

1 reference

1 reference

Patrick J Schuler

1

1 reference

11 August 2017

V Börger

2

1 reference

11 August 2017

E Bölke

3

1 reference

11 August 2017

D Habermehl

4

1 reference

11 August 2017

C Matuschek

5

1 reference

11 August 2017

C A Wild

6

1 reference

11 August 2017

J Greve

7

1 reference

11 August 2017

M Bas

8

1 reference

11 August 2017

B Schilling

9

1 reference

11 August 2017

C Bergmann

10

1 reference

11 August 2017

S Trellakis

11

1 reference

11 August 2017

W Budach

12

1 reference

11 August 2017

T Gauler

13

1 reference

11 August 2017

S Brandau

14

1 reference

11 August 2017

S Lang

15

1 reference

11 August 2017

T L Whiteside

16

1 reference

11 August 2017

R V Sorg

17

1 reference

11 August 2017

T K Hoffmann

18

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

European Journal of Medical Research

11 August 2017

1 reference

11 August 2017

16

1 reference

11 August 2017

2

1 reference

11 August 2017

57-62

1 reference

Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

Regulatory T cells in tumor immunity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

Tricks tumors use to escape from immune control

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

Mechanisms and treatment of allergic disease in the big picture of regulatory T cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

Anti-tumor vaccines in head and neck cancer: targeting immune responses to the tumor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

Dendritic cells for active immunotherapy: optimizing design and manufacture in order to develop commercially and clinically viable products

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

Manipulating dendritic cell biology for the active immunotherapy of cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

Dendritic cell biology and cancer therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

CD83 on dendritic cells: more than just a marker for maturation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck

2 October 2017

1 reference

https://api.crossref.org/works/10.1186%2F2047-783X-16-2-57

Cellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2047-783X-16-2-57

Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2047-783X-16-2-57

Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3353422

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

24 September 2018

1 reference

https://api.crossref.org/works/10.1186%2F2047-783X-16-2-57

Diagnostic value of regulatory T cells: a new facet of a much studied cell population

21 January 2018

1 reference

12 December 2020

Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival

1 reference

12 December 2020

Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Clinical-scale generation of dendritic cells in a closed system

1 reference

12 December 2020

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

12 December 2020

Human platelets target dendritic cell differentiation and production of proinflammatory cytokines

1 reference

12 December 2020

CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients

1 reference

12 December 2020

Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells

1 reference

12 December 2020

Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?

1 reference

12 December 2020

10.1186/2047-783X-16-2-57

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

21463982

1 reference